Case number IPR2016-01665
Amerigen Pharmaceuticals Limited v. UCB Pharma GmbH > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Aug 22, 2016 | 1 | Petition Download | |
| Aug 22, 2016 | 2 | Power of Attorney Download | |
| Aug 22, 2016 | 3 | Motion for Joinder Download | |
| Aug 22, 2016 | 4 | Certificate of Word Count Download | |
| Aug 29, 2016 | 5 | Notice of Accord Filing Date Download | |
| Sep 9, 2016 | 6 | Patent Owner Mandatory Notice Information Download | |
| Sep 9, 2016 | 7 | Patent Owner Power of Attorney Download | |
| Dec 7, 2016 | 8 | Trial Instituted Document Download | |
| Jul 19, 2017 | 9 | FINAL WRITTEN DECISION - Finding Claims 1–5 and 21–24 Not Unpatentable - Dismissing as Moot Patent Owner’s Motion to Exclude - Granting Joint Motion to Seal and Entering Default Protective Order Download | |
| Sep 20, 2017 | 10 | Notice of Appeal Download | |
| Apr 22, 2019 | 11 | CAFC Decision - Entered 1/11/19 Download | |
| Apr 22, 2019 | 12 | CAFC Mandate Download | |
| Aug 22, 2016 | 1001 | 1001 U.S.P.N. 6,858,650 Download | |
| Aug 22, 2016 | 1002 | 1002 File History for U.S.P.N. 6,858,650 - Part 1 Download | |
| Aug 22, 2016 | 1003 | 1003 Declaration of Steven E. Patterson, Ph.D Download | |
| Aug 22, 2016 | 1004 | 1004 C.V. for Dr. Steven Patterson, Ph.D Download | |
| Aug 22, 2016 | 1005 | 1005 Johansson WO 9411337 Download | |
| Aug 22, 2016 | 1006 | 1006 Andersson Review BJU International 1999 Download | |
| Aug 22, 2016 | 1007 | 1007 Brynne 1997 Download | |
| Aug 22, 2016 | 1008 | 1008 Thomas British Heart Journal 1995 Download | |
| Aug 22, 2016 | 1009 | 1009 Detrol Label Pharmacia and Upjohn Download | |
| Aug 22, 2016 | 1010 | 1010 Postlind Drug Metabolism and Disposition 1998 Download | |
| Aug 22, 2016 | 1011 | 1011 Brynne 1998 Download | |
| Aug 22, 2016 | 1012 | 1012 Bundgaard Design of Prodrugs 1985 - Part 1 Download | |
| Aug 22, 2016 | 1013 | 1013 Berge 1977. Download | |
| Aug 22, 2016 | 1014 | 1014 Anderson 1998 Download | |
| Aug 22, 2016 | 1015 | 1015 Nilvebrant Pharmacology and Toxicology 1997 Download | |
| Aug 22, 2016 | 1016 | 1016 DeMaagd 2012 Download | |
| Aug 22, 2016 | 1017 | 1017 Appell - Urology 1997 Download | |
| Aug 22, 2016 | 1018 | 1018 Ashworth - Home Care Provider 1997 Download | |
| Aug 22, 2016 | 1019 | 1019 Lipinski - Advanced Drug Delivery Reviews 1997 Download | |
| Aug 22, 2016 | 1020 | 1020 Bundgaard - WO 9208459 Download | |
| Aug 22, 2016 | 1021 | 1021 AUA Guideline Download | |
| Aug 22, 2016 | 1022 | 1022 Pfizer 2012 Press Release Download | |
| Aug 22, 2016 | 1023 | 1023 PM360 - April 1, 2012 Overactive Bladder Market Download | |
| Aug 22, 2016 | 1024 | 1024 Toviaz Label - Pfizer Labs Download | |
| Aug 22, 2016 | 1025 | 1025 FDA Approval Letter - NDA20-771 Download | |
| Aug 22, 2016 | 1026 | 1026 FDA Guidance - October 1999 Download | |
| Aug 22, 2016 | 1027 | 1027 Gould - International Journal of Pharmaceutics 1986 Download | |
| Aug 22, 2016 | 1028 | 1028 Alabaster 1997 Download | |
| Aug 22, 2016 | 1029 | 1029 Takeuchi 1997 Download | |
| Aug 22, 2016 | 1030 | 1030 Goldberg 1997 Download | |
| Aug 22, 2016 | 1031 | 1031 Begley 1996 Download | |
| Aug 22, 2016 | 1032 | 1032 Dkt 6 2015-01-28 Summons 15-cv-00079, Pfizer,et al v Mylan Pharm Download | |
| Aug 22, 2016 | 1033 | 1033 Declaration of DeForest McDuff, Ph.D. Download | |
| Aug 22, 2016 | 1034 | 1034 CV for DeForest McDuff, Ph.D. Download | |
| Aug 22, 2016 | 1035 | 1035 Toviaz - Don't Let Overactive Bladder Stop You In Your Tracks Download | |
| Aug 22, 2016 | 1036 | 1036 Toviaz U.S. and Worldwide Sales Download | |
| Aug 22, 2016 | 1037 | 1037 U.S. OAB Prescriptions and Shares by Drug 2008-2014 Download | |
| Aug 22, 2016 | 1038 | 1038 U.S. OAB Sales and Shares by Drug 2008-2014 Download | |
| Aug 22, 2016 | 1039 | 1039 U.S. OAB Market Share Prescriptions and Sales by Drug 2000-2007 Download | |
| Aug 22, 2016 | 1040 | 1040 Prescription Path of Toviaz and Other OABs Download | |
| Aug 22, 2016 | 1041 | 1041 Sales Path of Toviaz and Other OABs Download | |
| Aug 22, 2016 | 1042 | 1042 Sales Path of Toviaz Compound to Pharmaceutical Industry Benchmarks Download | |
| Aug 22, 2016 | 1043 | 1043 Comparison of Toviaz Sales to Compound to Pharmaceutical Industry Download | |
| Aug 22, 2016 | 1044 | 1044 Chart of Sales Path of Toviaz Download | |
| Aug 22, 2016 | 1045 | 1045 Present Value of Toviaz U.S. Sales Download | |
| Aug 22, 2016 | 1046 | 1046 Present Value of Toviaz Worldwide Sales Download | |
| Aug 22, 2016 | 1047 | 1047 Estimates of Expected RandD Costs Download | |
| Aug 22, 2016 | 1048 | 1048 U.S. OAB Detail Shares by Drug 2008-2015 Download | |
| Aug 22, 2016 | 1049 | 1049 Consumer Price Index Download | |
| Aug 22, 2016 | 1050 | 1002 File History for U.S.P.N. 6,858,650 - Part 2 Download | |
| Aug 22, 2016 | 1051 | 1002 File History for U.S.P.N. 6,858,650 - Part 3 Download | |
| Aug 22, 2016 | 1052 | 1002 File History for U.S.P.N. 6,858,650 - Part 4 Download | |
| Aug 22, 2016 | 1053 | 1012 Bundgaard Design of Prodrugs 1985 - Part 2 Download | |
| Aug 22, 2016 | 1054 | 1012 Bundgaard Design of Prodrugs 1985 - Part 3 Download | |
| Aug 22, 2016 | 1055 | 1012 Bundgaard Design of Prodrugs 1985 - Part 4 Download |
